Encompass Health Corporation Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain
Encompass Health Corporation (EHC) reported Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Income Statement › Other Income
us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain · last filed 2022-02-25
- Encompass Health Corporation business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2020-12-31 was $0.00.
- Encompass Health Corporation business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2019-12-31 was $0.00.
- Encompass Health Corporation business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2019-09-30 was $19.20M.
- Encompass Health Corporation business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2018-12-31 was $0.00.
- Encompass Health Corporation business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2021 was $0.00.
- Encompass Health Corporation business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Encompass Health Corporation business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2019 was $19.20M.
- Encompass Health Corporation business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2018 was $0.00.
| Period end | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 3 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 6 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 9 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-25 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $0.00 10-K · filed 2022-02-25 | ||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-02 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $19.20M derived: sum of 2 quarters · filed 2022-02-25 | $19.20M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $19.20M 10-Q · filed 2020-11-02 | $19.20M 10-Q · filed 2020-11-02 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $0.00 10-K · filed 2021-02-26 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-10-31 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $0.00 8-K · filed 2017-09-19 | |||
| 2015-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2017-09-19 | $0.00 derived: sum of 2 quarters · filed 2017-09-19 | $0.00 8-K · filed 2017-09-19 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $0.00 10-Q · filed 2015-10-29 | ||
| 2015-06-30 | $0.00 10-Q · filed 2015-07-30 | |||
| 2014-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2017-09-19 | $0.00 derived: sum of 2 quarters · filed 2017-09-19 | $27.20M 8-K · filed 2017-09-19 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $27.20M 10-Q · filed 2015-10-29 | ||
| 2014-06-30 | $27.20M 10-Q · filed 2015-07-30 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $0.00 10-K · filed 2016-02-25 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $0.00 10-Q · filed 2014-10-28 | ||
| 2013-06-30 | $0.00 10-Q · filed 2014-07-29 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |